ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) is a blank-check company sponsored by Perceptive Life Sciences Management, LLC, an affiliate of Perceptive Advisors, a healthcare-focused investment manager with deep roots in life sciences investing. The vehicle completed its initial public offering in 2021, targeting acquisition opportunities in the biopharmaceutical and life sciences sector. A Form 425 communication filed with the Securities and Exchange Commission in July 2024 reflects active business combination activity, indicating the company was engaged in a proposed transaction at that time. ARYD is the fourth vehicle in the ARYA Sciences series of dedicated life sciences SPACs. For full filing history, deal timelines, and analytics on ARYD and hundreds of other SPACs, sign up for SpacDesk.